Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New weight loss drug decreases appetite without nausea — and can even burn calories
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie burning — without any signs of nausea.
Weight Loss Drug Curbs Appetite, Burns Energy, Skips Side Effects
Researchers believe discovery will springboard research to make more tolerable, effective weight loss treatments accessible to millions more individuals.
New Drug CagriSema May Lead to 10% More Weight Loss Than Wegovy or Ozempic
Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs Ozempic and Wegovy. Novo Nordisk, the manufacturer of both, recently shared that CagriSema may lead to 10 percent more weight loss than Wegovy.
Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss?
There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether you have type 2 diabetes or obesity, you may have heard about medications like Ozempic® that can help manage blood sugar levels and weight.
New weight loss drug could be a 'better Ozempic'
Weather conditions complicating efforts to get New Jersey wildfire under control Deion Sanders imposed harsh punishment on Colorado players after they disregarded his game plan Princess Kate Revived Queen Elizabeth’s Remembrance Day Tradition The unhealthiest fast-food sandwich in America isn't a Big Mac,
New weight loss drug target reduces appetite and burns calories without sickness
The discovery could lead to a new treatment for millions of people with obesity and type 2 diabetes who do not respond well to current treatments.
5h
on MSN
Surging diabetes rate underscores vast opportunity in weight-loss drugs
The number of adults diagnosed with diabetes has more than quadrupled since 1990 and now stands above 800 million, according ...
FoodBusinessNews
3h
Hershey acknowledges ‘mild impact’ from GLP-1 drugs
HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...
2d
on MSN
Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle — from addiction to Alzheimer’s
Even if you you’re not diabetic or obese, can Ozempic be right for you? Ever since the weekly injectable was approved in 2017 ...
Seeking Alpha
52m
Global increase in diabetes indicates more room for GLP-1 meds to grow
A recent study that found there has been a massive increase in type 2 diabetes cases worldwide since 1990 is an indication that the market for
GLP-1
drugs could likely be ... Novo and Lilly also ...
New Atlas
4d
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...
MedPage Today on MSN
3d
ObesityWeek Roundup: Patients More Likely to Ration Weight-Loss Drugs
SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...
23h
Hims & Hers launches GLP-1 drug shortage tracker
Hims & Hers (HIMS) has launched an online GLP-1 supply tracker where people can share information about where the popular ...
FierceBiotech
1d
High-flying Metsera follows phase 1 weight loss data with $215M series B raise
They include MET-233i, an injectable amylin analog that is Metsera’s answer to the sector’s search for a once-monthly dosing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Food and Drug Administration
Ozempic
Wegovy
stroke
Novo Nordisk
Feedback